The 25-year follow-up of the GÖTEBORG-1 trial 5 assessing active surveillance for screen-detected low and intermediate risk ...
Roswell Park urology experts shared studies at AUA 2026 on bladder and prostate cancer risk, pelvic floor neural mapping and ...
Abstract: Gleason grading, the clinical gold standard for prostate cancer assessment, is based on subjective evaluation of glandular architecture, resulting in interobserver variability and limited ...
Background: To compare Gleason 7 (3+4) and (4+3) prostatic adenocarcinoma (PC) with different prognostic criteria through immunohistochemical analysis with anti-PSA, anti-Ki 67 and anti-AMARC ...
Risk stratification in localized prostate cancer relies primarily on Grade group (GG). In GG2-4 disease, risk assignment depends on the proportions of pattern 3 and pattern 4. We hypothesized that ...
Althopugh current prostate cancer biomarkers have improved the detection of clinically significant disease (Gleason Grade Group 2+), they fail to distinguish between high-grade cancer and genuinely ...
Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when "watchful waiting" may be the best approach.
Decipher genomic classifier scores combined with Gleason grade group improve risk stratification for prostate cancer patients on active surveillance. Patients with GG1 and high genomic classifier ...
Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results